We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Can BWX Technologies Benefit From the Commercial Nuclear Revival?
Read MoreHide Full Article
Key Takeaways
BWXT's commercial nuclear segment is emerging as a key growth driver alongside its U.S. Navy business.
BWXT's Commercial Operations revenues jumped 121% in Q1 2026, supported by broad-based nuclear demand.
BWXT expanded its U.S. manufacturing footprint as Commercial Operations backlog reached nearly $1.72 billion.
BWX Technologies (BWXT - Free Report) has long been recognized as the primary supplier of nuclear reactors and fuel for the U.S. Navy. While this government business continues to provide stable, long-term revenues, the company's commercial nuclear segment is emerging as an increasingly important growth engine.
Governments across North America and Europe are extending the operating lives of existing reactors while supporting the development of next-generation nuclear technologies, including small modular reactors ("SMRs") and advanced microreactors. These projects require specialized nuclear components, precision manufacturing, fuel handling systems, and engineering expertise — areas where BWXT has built decades of experience.
In April 2026, BWXT announced the acquisition of Precision Components Group, LLC. This marks BWXT’s first step in establishing a U.S. commercial nuclear component manufacturing footprint to support future new reactor builds and aftermarket.
During the first quarter of 2026, Commercial Operations revenues surged 121% year over year to $283.6 million, driven by strong demand for commercial nuclear components, field services, fuel and fuel-handling products, medical isotope sales, and contributions from Kinectrics.
BWXT reported a Commercial Operations book-to-bill ratio of 1.0 during the quarter, reflecting steady bookings from commercial nuclear components and field services. Kinectrics generated a book-to-bill ratio above 1.0, indicating that new orders continued to outpace revenue recognition.
Commercial Operations continues to build a robust backlog, providing strong visibility into future revenue growth. As of March 31, 2026, BWXT's Commercial Operations backlog reached nearly $1.72 billion, reflecting sustained demand for commercial nuclear components, engineering and field services, fuel handling solutions, and medical isotope products.
Nuclear Companies Positioned for the Commercial Expansion
BWX Technologies is not alone in benefiting from the renewed interest in commercial nuclear energy. Several companies are capitalizing on this long-term industry trend.
Cameco (CCJ - Free Report) continues expanding its uranium production and benefits from increasing global demand for nuclear fuel as utilities secure long-term supply contracts.
NuScale Power (SMR - Free Report) is focused on commercializing SMRs, targeting utilities, industrial customers, and data centers seeking reliable carbon-free electricity.
BWXT Stock’s Earnings Estimates
The Zacks Consensus Estimate for 2026 earnings per share indicates an increase of 14.76% year over year.
Image Source: Zacks Investment Research
BWXT Stock Trades at a Discount
In terms of valuation, BWXT’s forward 12-month price-to-sales (P/S) is 4.5X, a discount to the industry’s average of 12.98X.
Image Source: Zacks Investment Research
BWXT Stock’s Price Performance
In the past six months, shares of the company have risen 12.6% compared with the industry’s 13.8% growth.
View the Zacks #1 Rank List
Image: Bigstock
Can BWX Technologies Benefit From the Commercial Nuclear Revival?
Key Takeaways
BWX Technologies (BWXT - Free Report) has long been recognized as the primary supplier of nuclear reactors and fuel for the U.S. Navy. While this government business continues to provide stable, long-term revenues, the company's commercial nuclear segment is emerging as an increasingly important growth engine.
Governments across North America and Europe are extending the operating lives of existing reactors while supporting the development of next-generation nuclear technologies, including small modular reactors ("SMRs") and advanced microreactors. These projects require specialized nuclear components, precision manufacturing, fuel handling systems, and engineering expertise — areas where BWXT has built decades of experience.
In April 2026, BWXT announced the acquisition of Precision Components Group, LLC. This marks BWXT’s first step in establishing a U.S. commercial nuclear component manufacturing footprint to support future new reactor builds and aftermarket.
During the first quarter of 2026, Commercial Operations revenues surged 121% year over year to $283.6 million, driven by strong demand for commercial nuclear components, field services, fuel and fuel-handling products, medical isotope sales, and contributions from Kinectrics.
BWXT reported a Commercial Operations book-to-bill ratio of 1.0 during the quarter, reflecting steady bookings from commercial nuclear components and field services. Kinectrics generated a book-to-bill ratio above 1.0, indicating that new orders continued to outpace revenue recognition.
Commercial Operations continues to build a robust backlog, providing strong visibility into future revenue growth. As of March 31, 2026, BWXT's Commercial Operations backlog reached nearly $1.72 billion, reflecting sustained demand for commercial nuclear components, engineering and field services, fuel handling solutions, and medical isotope products.
Nuclear Companies Positioned for the Commercial Expansion
BWX Technologies is not alone in benefiting from the renewed interest in commercial nuclear energy. Several companies are capitalizing on this long-term industry trend.
Cameco (CCJ - Free Report) continues expanding its uranium production and benefits from increasing global demand for nuclear fuel as utilities secure long-term supply contracts.
NuScale Power (SMR - Free Report) is focused on commercializing SMRs, targeting utilities, industrial customers, and data centers seeking reliable carbon-free electricity.
BWXT Stock’s Earnings Estimates
The Zacks Consensus Estimate for 2026 earnings per share indicates an increase of 14.76% year over year.
Image Source: Zacks Investment Research
BWXT Stock Trades at a Discount
In terms of valuation, BWXT’s forward 12-month price-to-sales (P/S) is 4.5X, a discount to the industry’s average of 12.98X.
Image Source: Zacks Investment Research
BWXT Stock’s Price Performance
In the past six months, shares of the company have risen 12.6% compared with the industry’s 13.8% growth.
Image Source: Zacks Investment Research
BWXT’s Zacks Rank
The company currently has a Zacks Rank #3 (Hold). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.